The HPV vaccine Gardasil, approved for use in females in 2006, was approved for males in 2009. Gardisal is approved for boys and men ages 9 to 26 for the prevention of genital warts caused by two HPV strains: HPV 6 and HPV 11. Those are two of the four HPV strains that Gardasil targets.